Drug Manufacturers - Specialty & Generic · Healthcare
CEO, Board Member
2017-01-01–2022-12-31
Kåre Schultz
Equibles does not estimate personal net worth.
About Kåre Schultz
Kåre Schultz was last confirmed as CEO at Teva Pharmaceutical Industries Ltd (TEVA) in a filing dated April 19, 2023. Earlier roles on record: CEO and Board Member at Teva Pharmaceutical Industries Ltd (TEVA) until December 31, 2022. Teva Pharmaceutical Industries Ltd reported in an 8-K filed November 21, 2022 that Kåre Schultz retired as member of the Board of Directors, effective December 31, 2022. Teva Pharmaceutical Industries Ltd reported in an 8-K filed November 21, 2022 that Kåre Schultz retired as President and Chief Executive Officer, effective December 31, 2022. The proxy statement of Teva Pharmaceutical Industries Ltd reports total compensation of $15,529,138 for Kåre Schultz in fiscal 2022, including a base salary of $2,000,000. Disclosed compensation is on record for 6 fiscal years.
“Kåre Schultz and the Company’s Board of Directors have mutually agreed that Mr. Schultz will retire from his current positions as President and Chief Executive Officer, and a member of the Board of Directors, effective December 31, 2022.”
“Kåre Schultz and the Company’s Board of Directors have mutually agreed that Mr. Schultz will retire from his current positions as President and Chief Executive Officer, and a member of the Board of Directors, effective December 31, 2022.”
Affiliation history
-
2017-01-01–2022-12-31
-
Start not stated–2023-04-19
Last confirmed by a filing; no departure on record
-
Start not stated–2022-12-31
-
Start not stated–2022-12-31
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Teva Pharmaceutical Industries Ltd (TEVA) | President and Chief Executive Officer | $2,000,000 | $15,529,138 |
| 2021 | Teva Pharmaceutical Industries Ltd (TEVA) | President and Chief Executive Officer | $2,000,000 | $14,681,772 |
| 2020 | Teva Pharmaceutical Industries Ltd (TEVA) | President and Chief Executive Officer | $2,000,000 | $15,724,518 |
| 2019 | Teva Pharmaceutical Industries Ltd (TEVA) | President and Chief Executive Officer | $2,000,000 | $11,596,564 |
| 2018 | Teva Pharmaceutical Industries Ltd (TEVA) | President and Chief Executive Officer | $2,000,000 | $32,469,875 |
| 2017 | Teva Pharmaceutical Industries Ltd (TEVA) | President and Chief Executive Officer | $333,333 | $17,027,741 |